Vor Biopharma (VOR) Treasury Shares (2022 - 2026)

Vor Biopharma (VOR) has 5 years of Treasury Shares data on file, last reported at $346325.0 in Q1 2026.

• Treasury Shares for Q1 2026 came in at $346325.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $346325.0 (changed N/A YoY), and the FY2025 annual result was $186325.0, up 182.11% from the prior year.
• Treasury Shares climbed to $346325.0 in Q1 2026 per VOR's latest filing, from $186325.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $1.4 million in Q4 2022 and troughed at $66046.0 in Q4 2024.
• A 5-year average of $628455.4 and a median of $346325.0 in 2026 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares tumbled 94.07% in 2024, then soared 182.11% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.4 million in 2022, then fell by 22.15% to $1.1 million in 2023, then plunged by 94.07% to $66046.0 in 2024, then soared by 182.11% to $186325.0 in 2025, then jumped by 85.87% to $346325.0 in 2026.
• Business Quant data shows VOR's Treasury Shares at $346325.0 in Q1 2026, $186325.0 in Q4 2025, and $66046.0 in Q4 2024.